Skip to main content

Lanxess, Standard Lithium agree on next steps

Lanxess and Standard Lithium have signed an agreement under which the latter will conduct a front-end engineering design study to evaluate the economic viability and technical feasibility of an industrial-scale, battery grade, lithium carbonate plant at Lanxess’ site at El Dorado, Arkansas. This follows 20 months of testing at a pilot plant.

The final results are expected in Q4, the two companies stated. If the study is completed successful, Standard Lithium could build a plant at its own expense at one of the three sites in El Dorado.

Preventol boost at Lanxess

At the cost of “a single-digit million euro amount”, Lanxess’s Material Protection Products (MPP) business unit is expanding capacity for the active ingredient Preventol CMK (chlorocresol) at Krefeld-Uerdingen, Germany, by around 50%. This will be completed within Q1 the firm said.

Lanxess to acquire IFF’s microbial control business

Lanxess has signed a corresponding agreement to acquire the microbial control business of International Flavors & Fragrances (IFF) for $1.3 billion or 9.6x EBITA. The deal should be completed in Q2 2022, following a carve-out process and subject to regulatory approvals. This is the firm’s second largest ever buy, just ahead of the recently completed acquisition of Emerald Kalama.

Two dead, many injured in Chempark explosion

Two workers have been confirmed dead after an explosion at Chempark Leverkusen in Germany at around 09.40 on 27 July and a subsequent fire in the tank farm of the Bürrig disposal centre that sent a blanket of smoke across the city and was heard 40 kilometres away.

Lanxess enters battery chemistry

Lanxess has announced that it will be entering the battery chemistry business from 2022. It will produce electrolyte formulations for lithium-ion batteries for China’s Guangzhou Tinci Materials Technology using a plant operated by Saltigo in Germany. Further details were not disclosed.

Lanxess to buy Emerald Kalama

LanxessLanxess has signed a binding agreement to acquire Emerald Kalama Chemical from private equity firm American Securities for €867 million. The deal, which will be financed from existing liquidity, should be completed in Q2, subject to approval by the relevant authorities.

Subscribe to Lanxess